Resources for Managing and Procuring Rare Disease Medical Devices in the United States

Summary

• Hospital administrators can utilize group purchasing organizations (GPOs) to access discounted pricing and streamline procurement processes for rare disease medical devices
• The FDA's Orphan Drug Designation program provides incentives for manufacturers to develop medical devices for rare diseases, increasing the availability of these devices for hospitals
• The National Organization for Rare Disorders (NORD) and the Rare Disease Innovation and Market Accessibility Act (the R-DIMA Act) are resources that hospital administrators can leverage to advocate for better access to rare disease medical devices

In the United States, hospital administrators face unique challenges when it comes to managing and procuring medical devices for rare diseases. Rare diseases, also known as orphan diseases, affect a small percentage of the population and often lack effective treatments. The limited availability of medical devices for rare diseases can pose challenges for hospitals looking to provide the best possible care for patients with these conditions. In this article, we will explore the resources available to hospital administrators to effectively manage and procure rare disease medical devices in the United States.

Group Purchasing Organizations

Group Purchasing Organizations (GPOs) are entities that leverage the collective purchasing power of multiple Healthcare Providers to negotiate discounted pricing for medical devices and supplies. By joining a GPO, hospital administrators can access a wide range of rare disease medical devices at competitive prices. GPO contracts can help streamline the procurement process, reduce administrative costs, and ensure that hospitals have access to the latest medical devices for rare diseases.

Key benefits of utilizing GPOs for rare disease medical device procurement include:

1. Access to discounted pricing on a wide range of medical devices
2. Streamlined procurement processes, including centralized billing and order tracking
3. Ability to leverage the purchasing power of a larger group of providers

FDA Orphan Drug Designation Program

The Food and Drug Administration (FDA) offers a special designation for drugs and medical devices used to treat rare diseases called Orphan Drug Designation. This program provides manufacturers with incentives to develop medical devices for rare diseases, including tax credits for clinical research expenses, market exclusivity, and waived FDA fees. By incentivizing the development of medical devices for rare diseases, the Orphan Drug Designation program helps to increase the availability of these devices for hospitals and patients.

Key benefits of the FDA Orphan Drug Designation program for hospital administrators include:

1. Increased availability of medical devices for rare diseases
2. Access to innovative treatments and therapies for patients with rare diseases
3. Opportunity to participate in clinical trials for new medical devices

National Organization for Rare Disorders (NORD)

The National Organization for Rare Disorders (NORD) is a patient advocacy organization that provides support and resources for individuals and families affected by rare diseases. NORD offers a variety of programs and services to help patients access medical devices and treatments, including advocacy and education initiatives. Hospital administrators can collaborate with NORD to advocate for better access to rare disease medical devices and ensure that patients with rare diseases receive the care they need.

Key resources available through NORD for hospital administrators include:

1. Patient advocacy programs to support patients with rare diseases
2. Access to educational resources and webinars on rare diseases and medical devices
3. Collaboration opportunities to advocate for improved access to rare disease treatments

Rare Disease Innovation and Market Accessibility Act (R-DIMA Act)

The Rare Disease Innovation and Market Accessibility Act (the R-DIMA Act) is a federal bill aimed at improving access to rare disease treatments, including medical devices. The R-DIMA Act proposes several measures to incentivize the development of medical devices for rare diseases, such as tax credits for research and development expenses, streamlined FDA approval processes, and increased funding for rare disease research. Hospital administrators can support the R-DIMA Act and other legislative efforts to improve access to rare disease medical devices for patients.

Key provisions of the R-DIMA Act that are relevant to hospital administrators include:

1. Incentives for manufacturers to develop medical devices for rare diseases
2. Streamlined FDA approval processes for rare disease treatments
3. Increased funding for rare disease research and innovation

Managing and procuring medical devices for rare diseases can be a complex and challenging task for hospital administrators in the United States. By utilizing resources such as Group Purchasing Organizations, the FDA Orphan Drug Designation program, the National Organization for Rare Disorders, and the Rare Disease Innovation and Market Accessibility Act, hospital administrators can improve access to rare disease medical devices and ensure that patients with rare diseases receive the best possible care. By advocating for better access to rare disease treatments and collaborating with patient advocacy organizations and policymakers, hospital administrators can make a significant impact on the lives of individuals and families affected by rare diseases.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos